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A B S T R A C T
Background: Frequent Cannabis use has been linked to a variety of negative mental, physical, and social con-
sequences. We assessed the eﬀects of digital prevention and treatment interventions on Cannabis use reduction
in comparison with control conditions.
Methods: Systematic review with two separate meta-analyses. Thirty randomized controlled trials met the in-
clusion criteria for the review, and 21 were included in the meta-analyses. Primary outcome was self-reported
Cannabis use at post-treatment and follow-up. Hedges’s g was calculated for all comparisons with non-active
control. Risk of bias was examined with the Cochrane risk-of-bias tool.
Results: The systematic review included 10 prevention interventions targeting 8138 participants (aged 12 to 20)
and 20 treatment interventions targeting 5195 Cannabis users (aged 16 to 40). The meta-analyses showed
signiﬁcantly reduced Cannabis use at post-treatment in the prevention interventions (6 studies, N=2564,
g=0.33; 95% CI 0.13 to 0.54, p= 0.001) and in the treatment interventions (17 comparisons, N=3813,
g=0.12; 95% CI 0.02 to 0.22, p= 0.02) as compared with controls. The eﬀects of prevention interventions
were maintained at follow-ups of up to 12 months (5 comparisons, N=2445, g=0.22; 95% CI 0.12 to 0.33,
p < 0.001) but were no longer statistically signiﬁcant for treatment interventions.
Conclusions: Digital prevention and treatment interventions showed small, signiﬁcant reduction eﬀects on
Cannabis use in diverse target populations at post-treatment compared to controls. For prevention interventions,
the post-treatment eﬀects were maintained at follow-up up to 12 months later.
1. Introduction
Cannabis is globally one of the most widely used substances, with
average lifetime prevalence rates of 46% among adults in the USA
(CBHSQ, 2016), 35% in Australia (AIHW, 2017), and 26% in Europe
(EMCDDA, 2018). Although Cannabis is commonly viewed as a
harmless drug in Western cultures (Hurd et al., 2014), frequent Can-
nabis use has been found to be associated with a variety of negative
mental, physical, and social consequences (Hall, 2015), such as
heightened risk for psychosis (Di Forti et al., 2015), reduced learning
ability (Houck et al., 2013), socioeconomic problems (Cerdá et al.,
2016), anxiety and panic attacks (Crippa et al., 2009), and reduced
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social functioning (Ansell et al., 2015). The severity of these health and
psychosocial problems increase with earlier ages of Cannabis use onset
(Gage et al., 2016; Lynskey et al., 2003).
Given the substantial impact that Cannabis use might have, a
variety of prevention and treatment options are in place to prevent and
treat Cannabis use in various target groups. Prevention interventions
mainly target young participants, regardless of their Cannabis use
status, since Cannabis initiation most commonly occurs during adoles-
cence (Coﬀey and Patton, 2016; Pinchevsky et al., 2012). Treatment
interventions focus on treatment-seeking Cannabis users. Several meta-
analyses have previously shown face-to-face prevention and treatment
interventions to be eﬀective in reducing Cannabis use in adolescents
and adults (Davis et al., 2015; Gates et al., 2016; Porath-Waller et al.,
2010).
However, as the numbers of Cannabis users rise and the demand for
prevention and treatment increases (Montanari et al., 2017), new
strategies should be evaluated that consider the limited capacities of
traditional prevention and treatment facilities. Digital prevention and
treatment interventions could be a novel approach to expand accessi-
bility of evidence-based health services. Speciﬁcally, by removing
barriers such as distance and stigmatization, such interventions can
make prevention and treatment available independent of time and
place, thus lowering the threshold to access care (Taylor and Luce,
2003) and potentially delivering a strong public health impact.
Unfortunately, few randomized controlled trials (RCTs) have yet
been conducted to assess digital prevention and treatment interventions
in terms of Cannabis use reduction, as was observed in two prior meta-
analyses (Olmos et al., 2018; Tait et al., 2013). The study by Tait and
colleagues (Tait et al., 2013) concluded that digital interventions ap-
peared to eﬀectively reduce Cannabis use in adolescents and adults at
post-treatment, albeit with a limited number of available RCTs (10
studies by 2012, 5 prevention and 5 treatment interventions). The
meta-analysis by Olmos and colleagues (Olmos et al., 2018) came to a
similar conclusion after identifying 9 RCTs (search conducted in 2015,
7 intervention and 2 prevention studies).
These previous meta-analyses did not distinguish in their inclusion
criteria between prevention and treatment interventions, which – given
the substantial diﬀerences, most notably in terms of target groups –
might have complicated the interpretation of the provided pooled eﬀect
estimates of Cannabis use reduction. Additionally, the previous meta-
analyses pooled together active and non-active control comparisons,
possibly inducing further heterogeneity and leading to ambiguity as to
absolute and relative treatment eﬃcacy. The ﬁeld has matured in
subsequent years, and we therefore decided to perform a systematic
review and two separate meta-analyses to assess the eﬀectiveness of
digital prevention and treatment interventions in reducing Cannabis
use at post-treatment and follow-up in comparison to control condi-
tions.
2. Methods
2.1. Identiﬁcation of studies
A systematic literature search was conducted up to October 10,
2018, identifying 419 potentially eligible studies through the following
databases: PubMed, EMBASE, PsycINFO, and the Cochrane Central
Register of Controlled Trials (see Appendix A for the full search string
we applied for PubMed). An RCT ﬁlter was applied. Our selection
strategy was based on titles and abstracts. We included interventions
that were internet- or computer-based, but for the sake of brevity we
will refer to the included interventions as digital interventions.
Subsequently, the full texts of studies were retrieved and assessed in
terms of inclusion criteria. The search and screening were performed by
two of the authors (N.B. and L.L.) independently; in cases of disagree-
ment, consensus was reached by discussion.
2.2. Eligibility criteria
The eligibility criteria varied slightly between our systematic review
and the meta-analyses. For the systematic review, we decided to include
RCTs of prevention and treatment interventions regardless of their in-
tervention type and control comparisons. Polysubstance use interven-
tions, targeting Cannabis use among other substances, were eligible as
long as Cannabis use was reported separately. A measure of Cannabis
use at post-treatment – assessed via self-report, toxicology screening or
both – had to be included. For the meta-analyses, we excluded pre-
vention and treatment interventions that were compared with active
control conditions, since inclusion of diﬀering comparators might have
resulted in ambiguous estimations of absolute and relative treatment
eﬃcacy (Karlsson and Bergmark, 2015). We also decided to include
only self-report outcomes in the meta-analyses, thereby excluding stu-
dies that reported toxicology screening outcomes only. Although tox-
icology screening is a reliable way to measure heavy Cannabis use, it is
less reliable for detecting mild use or frequency of use (Taylor et al.,
2017).
2.3. Quality assessment
The validity of all RCTs was assessed using the Cochrane risk-of-bias
tool (Higgins et al., 2011). Speciﬁcally, we assessed (a) adequacy of
allocation sequence generation, (b) concealment of the allocation to the
particular conditions, (c) blinding of the participants and personnel, (d)
blinding of the outcome assessors, (e) appropriate handling of in-
complete outcome data by utilizing an intention-to-treat (ITT) design,
(f) selective outcome reporting, and (g) other potential threats to va-
lidity. Risk of bias was independently evaluated by two of the authors
(N.B. and L.L.); in the event of disagreement, consensus was reached by
discussion.
2.4. Data extraction
Outcome measures assessing Cannabis use were extracted; these
included self-reported frequency of use or scores on self-report ques-
tionnaires, as recorded at post-treatment and furthest follow-up (3 to 12
months). We also extracted various characteristics of the studies.
2.5. Meta-analyses
All analyses were carried out with the computer program
Comprehensive Meta-Analysis (CMA, version 3.3.070). Eﬀect sizes were
calculated by subtracting the mean post-treatment result of the ex-
perimental condition from the mean post-treatment result of the control
condition and dividing that diﬀerence by the pooled standard deviation
of the two (Cohen, 1988), or by converting test statistics (F, r) into
standardized mean diﬀerences (Lipsey and Wilson, 2001). Eﬀect sizes of
about 0.8 can be considered large, 0.5 moderate, and 0.2 small (Cohen,
1988). For studies with two or more intervention conditions, we se-
parated the control condition into two or more groups, dividing the
sample size by that number (Becker et al., 2014; Blow et al., 2017;
Schaub et al., 2015). Subsequently, experimental conditions were
compared separately with the relevant control conditions. Hedges’s g
was computed to indicate the diﬀerence in eﬀect sizes for each com-
parison (Hedges and Olkin, 1985). As we anticipated heterogeneity
among the RCTs, we calculated the mean eﬀect sizes using a random-
eﬀects model, which implies that the included studies were drawn from
populations of studies that systematically diﬀered from one another
(Borenstein et al., 2009). To test the homogeneity of eﬀect sizes, we
calculated the I² heterogeneity statistic; an estimation of zero percent
suggests no heterogeneity, whereas 25%, 50%, and 75% suggest low,
moderate, and high heterogeneity. We further calculated 95% con-
ﬁdence intervals around I² (Ioannidis et al., 2007), applying the non-
central chi-square–based approach within the “heterogi” module for
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Stata (Orsini et al., 2006). We assessed publication bias by visually
inspecting the funnel plot. To assess whether the bias captured by the
funnel plot was signiﬁcant, we used Egger’s linear regression test of the
intercept (Egger et al., 1997). Duval and Tweedie’s trim-and-ﬁll pro-
cedure (Duval and Tweedie, 2000) was used to account for potentially
missing studies. The presence of outliers was explored by assessing
whether eﬀect sizes and 95% conﬁdence intervals of the studies over-
lapped with the 95% CI of the pooled eﬀect size; in cases where outliers
were observed, we conducted an additional analysis without the out-
liers. Characteristics which, according to the literature, may induce
heterogeneity and aﬀect eﬀect sizes were investigated in subgroup
analyses (see Table 4, Appendix B) using a mixed-eﬀects model
(Borenstein et al., 2009), whereby studies within subgroups were
pooled in a random-eﬀects model and analyses for signiﬁcant diﬀer-
ences between subgroups were conducted with a ﬁxed-eﬀects model.
Lastly, we conducted three univariable meta-regression analyses to
gauge associations between the eﬀect sizes of the digital prevention and
treatment interventions, based on self-reported Cannabis use at post-
treatment, and (a) intervention duration, (b) number of sessions, and
(c) the risk of bias of the assessed studies.
2.6. Power calculation
We calculated the number of RCTs needed to achieve adequate
statistical power to determine relevant post-treatment and follow-up
eﬀects (Borenstein et al., 2009). Assuming a small eﬀect size of g=0.20
– based on previously conducted meta-analyses (Olmos et al., 2018;
Tait et al., 2013) – with a medium level of between-study variance (τ2),
a statistical power of 0.80, and an alpha of 0.05, we calculated that 10
studies including a mean of 66 participants per condition would be
necessary, or 20 studies including 33 participants per condition. To
detect an eﬀect size of g=0.30, we would need 10 studies with 30
participants per condition or 20 studies with 15 per condition.
3. Results
3.1. Selection and inclusion of studies
From the 419 abstracts (307 after removal of duplicates), we re-
trieved 70 full-text papers for possible inclusion in our systematic re-
view; 40 of those were excluded because they did not meet our inclu-
sion criteria. A total of 30 studies met all criteria for the systematic
review (10 prevention interventions and 20 treatment interventions)
and 21 studies for the meta-analyses (6 prevention and 15 treatment
interventions). A ﬂowchart describing the inclusion process for the
systematic review and the meta-analyses is shown in Fig. 1.
3.2. Characteristics of included prevention interventions
The prevention interventions we identiﬁed for the systematic re-
view (n=10) included a total of 8138 participants (n=4635 in the
experimental conditions; n=3783 in the comparison conditions;
Table 1). The mean ages of their participants ranged from 12 to 20.
Four studies recruited participants from a secondary school, three from
the community, one from a university setting, one from a clinical set-
ting (unrelated to substance use), and one study recruited exclusively
via a social media website. As expected in universal prevention inter-
ventions, the RCTs included participants irrespective of their Cannabis
use status. The studies included more female (61.4%) than male par-
ticipants. Overall study attrition ranged from 1.5% to 55% and thus
varied considerably. Parent-involvement programs had the smallest
attrition rates, ranging from 1.5% to 5.7%, while Climate Schools
courses showed attrition rates ranging from 10.5% to 55%.
The majority of the included interventions (n=7) assessed baseline
Cannabis use, but it was measured in various ways. The most common
measure (n=5) was frequency of use during the previous 1, 3 or 6
months; the other studies (n=2) reported percentages of participants
with lifetime Cannabis use. Six of the studies applied an unguided di-
gital prevention intervention that oﬀered no additional support via
face-to-face contact or written communication (Elliott and Carey, 2012;
Fang et al., 2010; Schinke et al., 2009a, 2009b; Schwinn et al., 2010a;
Walton et al., 2014); four studies provided guidance via teacher-de-
livered class activity to reinforce the information taught in the online
components (Champion et al., 2016; Newton et al., 2018, 2010; Vogl
et al., 2014). Four of the studied interventions were targeting a variety
of substances including Cannabis, two targeted Cannabis use ex-
clusively via Cannabis-speciﬁc prevention interventions, three targeted
Cannabis and alcohol, and one study targeted Cannabis and psychos-
timulants.
Eleven comparisons were made, six of which were with non-active
comparison conditions (assessment-only, health information brochure)
and four with active conditions (drug prevention-as-usual). The applied
interventions varied (see Tables 1 and 3). Four studies evaluated Cli-
mate Schools courses in secondary schools (Champion et al., 2016;
Newton et al., 2010; Vogl et al., 2014), three studies assessed parent-
involvement programs (Fang et al., 2010; Schinke et al., 2009a, 2009b),
one study evaluated personalized normative feedback (PNF) (Elliott
and Carey, 2012), one study assessed a skills-based prevention program
(Schwinn et al., 2010b), and one study tested a brief intervention (BI)
based on harm reduction and motivational interviewing (MI) (Walton
et al., 2014). All the included RCTs employed self-report measures to
assess Cannabis use frequency. The studies were carried out in three
diﬀerent countries: USA (n=5), Australia (n=4), and Canada (n=1).
Study characteristics are shown in Table 1.
3.3. Quality assessment of the prevention interventions
The methodological quality of the prevention studies we included in
our ﬁrst meta-analysis (N=6) can be observed in detail in Appendix C.
One of the six studies reported adequate sequence generation. None
reported adequate allocation concealment. None blinded the partici-
pants and personnel. As all studies employed self-reporting scales to
measure Cannabis use, we considered this lack of blinding in the out-
come assessments to entail a high risk of bias; however, given the
context of universal prevention interventions, which target large
numbers of users and non-users, self-report measures seemed the most
realistic approach for measuring Cannabis use. Incomplete outcome
data was handled adequately in three studies. Regarding selective
outcome reporting, none of the studies had a publicly available protocol
or pre-registration, so they could not be assessed for possible protocol
violations. No other potential threats to validity were identiﬁed in the
included studies. In summary, three studies fulﬁlled one criterion of the
possible seven, two studies fulﬁlled two criteria, and one study fulﬁlled
three criteria.
3.4. Post-treatment and follow-up eﬀects of prevention interventions on
Cannabis use
The prevention interventions that were compared to active com-
parison conditions (4 studies, n=6647) – and which were therefore
not included in the ﬁrst meta-analysis (see Table 1) – reported no sig-
niﬁcant diﬀerences in Cannabis use between conditions at the follow-up
assessments. Speciﬁcally, the excluded studies compared the Climate
Schools intervention with drug prevention-as-usual. The prevention
interventions that were compared to non-active control conditions (6
studies, N=2564) showed a small signiﬁcant eﬀect (g=0.33; 95% CI
0.13 to 0.54) on Cannabis use at post-treatment. Heterogeneity was
high (see Fig. 2 and Table 4). No publication bias was indicated via
assessment of the funnel plot and Duval and Tweedie’s trim-and-ﬁll
procedure. Egger’s test did not indicate an asymmetric funnel plot (p=
0.58). At follow-up assessments up to 12 months later (5 studies,
n=2445), the eﬀect decreased slightly but remained statistically
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signiﬁcant (g=0.22; 95% CI 0.12 to 0.33, p= 0.001). Subgroup
analyses did not show signiﬁcant diﬀerences between groups (see
Table 4). The univariable meta-regression analyses did not reveal sig-
niﬁcant associations between the eﬀect sizes of the digital interventions
and (a) intervention duration in days (slope 0.003; 95% CI− 0.004 to
0.01, p= 0.421), (b) number of sessions in the intervention (slope
0.015; 95% CI −0.03 to 0.06, p= 0.548), or (c) risk of bias of the
studies (slope −0.03; 95% CI−0.34 to 0.28, p= 0.868). For the sake
of rigor, we additionally report in Appendix E the eﬀect on Cannabis
use of the non-included prevention interventions that were compared
with active control conditions.
3.5. Characteristics of included treatment interventions
The treatment interventions we identiﬁed for the systematic review
(n=20) recruited a total of 5195 participants (n=3007 in the ex-
perimental conditions; n=2188 in the comparison conditions;
Table 2). The mean ages of the participants ranged from 16 to 40; most
studies recruited adults aged 18 or older, while one study recruited
exclusively adolescents aged 12 to 17. Twelve studies recruited parti-
cipants with self-reported Cannabis use within varying time frames (e.g.
weekly, monthly use). Six studies recruited participants on the basis of
various scales: the Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST) (WHO Group, 2002), with scores from 4 to 26;
the Severity of Dependence Scale (SDS) (Gossop et al., 1995), with
scores of≥ 2 for females and≥ 4 for males; or the Opiate Treatment
Index (OTI) (Darke et al., 1992), with scores of≥ 0.16. One study re-
cruited participants based on a DSM-IV diagnosis indicating Cannabis
abuse or dependence, and a further study recruited participants ex-
pressing the wish to participate.
The included studies employed diﬀerent recruitment strategies. Ten
studies recruited from clinical settings, ﬁve from university settings,
three from the community, and two exclusively online. The studies
recruited slightly more male (52%) than female participants. Overall
study attrition ranged from 1.4% to 77.2%, thus diﬀering widely.
Notably, a brief intervention (BI) and a PNF-based intervention ex-
hibited the smallest attrition rates, ranging from 1.4% to 1.6%, while
the solution-focused therapy showed the highest rate at 77.2%. The
majority of the included interventions (n=17) assessed baseline
Cannabis use, though measured in various ways. The most common
measure (n=12) was the number of Cannabis use days in the previous
1 or 3 months; other studies reported the mean ASSIST Cannabis score
(n=4) or the percentage of participants using Cannabis at least once
during the study period (n=1). The baseline mean number of past-
month Cannabis use days was 18.3 (SD=10.95), based on ﬁve studies
and 1053 individuals; the mean ASSIST Cannabis score was 10.6
(SD=6.9), based on ﬁve studies and 1016 individuals.
Twelve RCTs applied an unguided digital intervention, while six
provided guidance in the form of therapist sessions or online chat,
during which the content of the interventions was discussed and feed-
back provided. Two studies consisted of a three-arm RCT oﬀering two
treatment interventions, with one arm being guided and the other
treatment arm unguided. The form of guidance diﬀered, in that one
study employed guidance via a chat module (Schaub et al., 2015) and
the other provided the intervention with face-to-face therapist guidance
(Blow et al., 2017). Eighteen studies applied a stand-alone digital in-
tervention without any additional treatment, while three studies pro-
vided an add-on digital intervention adjunctive to face-to-face treat-
ment by a mental health professional.
Eleven of the 20 studies in our systematic review targeted Cannabis
as the primary substance of abuse, using Cannabis-speciﬁc interven-
tions, whereas nine studies aimed to reduce Cannabis consumption via
polysubstance use interventions that also targeted Cannabis. In the 20
studies, 23 comparisons were made, in which 17 interventions were
compared with non-active control conditions (education, assessment-
only, waitlist) and 6 with active comparison conditions (person-cen-
tered therapy, brief intervention [BI], motivational interviewing [MI]
plus cognitive-behavioral therapy [CBT], counseling, enhanced usual
Fig. 1. Flowchart for inclusion of studies in systematic review and meta-analyses.
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care). The applied treatment interventions varied (see Tables 2 and 3).
Seven studies applied MI, ﬁve applied PNF, ﬁve applied combined CBT
and MI, two applied BI, and two employed other distinct types of in-
terventions (solution- focused therapy, community reinforcement ap-
proach [CRA]). The RCTs were conducted in ﬁve countries: USA
(n=12), Australia (n=3), Germany (n=2), Switzerland (n=2), and
Brazil (n=1). Study characteristics are shown in Table 2.
3.6. Quality assessment of the treatment interventions
The methodological quality of the treatment studies we included in
our second meta-analysis can be observed in detail in Appendix D.
Twelve of the 15 included RCTs reported adequate sequence genera-
tion. Seven reported adequate allocation concealment. Two RCTs
blinded the participants and personnel by fully automating the rando-
mization procedure online and ensuring that the participants were not
aware of the other conditions. As we decided to use the self-report
measures to assess Cannabis use, we considered the lack of blinding in
the outcome assessments to entail a high risk of bias in all studies –
excepting the two cases (Becker et al., 2014; Jonas et al., 2012) in
which participants were unaware of other study conditions and the
interventions were fully automated, thus ensuring a low risk of detec-
tion bias. Eleven studies adequately handled incomplete outcome data
through ITT analyses. Regarding selective outcome reporting, a pro-
tocol or pre-registration was publicly available in only ﬁve cases, so the
other studies could not be assessed for possible protocol violations. No
other potential threats to validity were identiﬁed in the included stu-
dies. In summary, two studies fulﬁlled one of the seven possible criteria,
two studies fulﬁlled two criteria, three studies fulﬁlled three criteria,
four studies fulﬁlled four criteria, two studies fulﬁlled ﬁve criteria, and
one study fulﬁlled seven criteria.
Table 3
Deﬁnitions of digital interventions for Cannabis users.
Conditions Deﬁnition N of studies
Motivational interviewing (MI) A distinct feature of MI is that the patient, rather than the therapist, is the one who voices the arguments
for change. MI is based on the person-centered approach of Carl Rogers (Rogers, 1951). In MI, the
conditions for growth and change are provided by the therapist, by creating an environment of an
egalitarian relationship. MI is distinct from a classic non-directive approach, since therapists in MI direct
their clients toward speciﬁc outcome goals, using systematic strategies to achieve those goals (Rollnick and
Miller, 1995).
8
Personalized normative feedback (PNF) PNF interventions provide tailored feedback delivered via self-report tools measuring substance use. The
feedback regarding individuals’ substance use behavior is commonly displayed through bar graphs and
compared with the perception they have of substance use norms within their speciﬁc reference group and
with the actual substance use behavior in that particular group (Dotson et al., 2015).
6
Motivational interviewing (MI) + cognitive-
behavioral therapy (CBT)
The combination of MI and CBT is a promising approach in which motivational strategies are applied to
initiate motivation for change, while CBT targets dysfunctional thoughts and behaviors that hinder
ordinary daily functioning (Naar-King and Safren, 2017).
5
Climate Schools courses The Climate Schools courses are based on a social inﬂuence approach within a harm reduction framework.
The interventions are implemented within school curricula. Climate Schools courses provide cartoon-based
educational information and are delivered through digital means (Newton et al., 2009).
4
Parent-involvement programs In the family prevention programs identiﬁed here, mother-daughter dyads are recruited with the aims of
positively inﬂuencing the daughters to adopt healthy, positive behaviors and of preventing risky behaviors
such as substance use initiation (Schinke et al., 2009b).
3
Brief interventions (BI) BIs are concise interventions taking place over a brief period of time. They promote a practical
conversation style designed to create a collaborative relationship with the patient. The goal is to work
together toward the patient’s self‐identiﬁed aims. BIs are solution-focused and are often associated with MI
techniques (Center for Substance Abuse Treatment, 1999).
3
Solution-focused approaches In solution-focused approaches, the main focus is on ﬁnding solutions for the present and on exploring
individuals’ hopes and goals, thereby identifying potential resolutions to problems (Iveson, 2002).
1
Skills-based prevention programs Skill-based prevention programs teach adolescents various skills for handling situations that might lead to
substance use initiation. Commonly targeted skills include self-eﬃcacy, goal setting, eﬀective
communication, dealing with peer pressure, problem solving, and decision making (Schinke et al., 2004).
1
Community reinforcement approach (CRA) CRA is an extensive behavioral program supporting patients through functional analyses to investigate
triggers and consequences of speciﬁc behaviors and to develop strategies to either avoid or address those
behaviors. CRA makes use of various incentives of a vocational, social, and recreational nature in order to
change patients’ circumstances (Meyers et al., 2005).
1
Fig. 2. Forest plot for cannabis use reduction in prevention interventions at post-treatment and follow-up (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article).
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3.7. The post-treatment and follow-up eﬀects of treatment interventions on
Cannabis use
The treatment interventions that were compared to active compar-
ison conditions (5 studies, n=1996) – and which were therefore not
included in the second meta-analysis (see Table 2) – reported varied
eﬀects. The study by Blow et al. (2017) found that a computer-delivered
BI was as eﬀective as a therapist-delivered BI, and that both interven-
tions were signiﬁcantly more eﬀective than enhanced usual care. The
study by Schwartz et al. (2014) found a computer-delivered BI to be
more eﬀective than a BI delivered by a behavioral health counselor.
Budney et al. (2015) reported that a computer-delivered MI+CBT
intervention was equally eﬀective to a therapist-delivered MI+CBT
intervention, and that both interventions were signiﬁcantly more ef-
fective than a therapist-delivered BI; interestingly, the computer-de-
livered intervention was signiﬁcantly more cost-eﬀective than the
therapist-delivered intervention. The study by Campbell et al. (2014)
suggested that counseling combined with internet-delivered CRA seems
promising for reducing Cannabis use outcomes as compared with
counseling-only delivery, although the eﬀects did not reach statistical
signiﬁcance. Finally, the study by Kay-Lambkin et al. (2011) reported
that Cannabis use outcomes were not signiﬁcantly diﬀerent among
computer-delivered MI+CBT, therapist-delivered MI+CBT, and
person-centered therapy (PCT).
Assessing the studies included in the meta-analysis (15 studies,
N=3813), we found a small signiﬁcant eﬀect (g=0.12; 95% CI 0.02
to 0.22) in terms of Cannabis use reduction at post-treatment for studies
comparing treatment interventions with non-active control conditions.
Heterogeneity was moderate (see Fig. 3 and Table 4). A visual assess-
ment of the forest plot indicated one possible outlier (Towe and
Stephens, 2014), in which the eﬀect size did not overlap with the 95%
CI of the pooled eﬀect size (Fig. 3). For this reason, we removed the
possible outlier, resulting in a minor decrease in the eﬀect size. No
publication bias was indicated via the assessment of the funnel plot and
Duval and Tweedie’s trim-and-ﬁll procedure. Egger’s test did not in-
dicate an asymmetric funnel plot (p= 0.89). At the follow-up assess-
ments of up to 12 months (9 studies), eﬀects did not reach signiﬁcance
(p= 0.10). The subgroup analyses we conducted did not indicate a
statistically signiﬁcant diﬀerence between the groups (Table 4). The
univariable meta-regression analyses did not reveal statistically sig-
niﬁcant associations between the eﬀect sizes of digital interventions
and (a) intervention duration in days (slope 0.005; 95% CI− 0.0006 to
0.01, p= 0.08), (b) number of sessions in the intervention (slope 0.03;
95% CI−0.01 to 0.06, p= 0.158), or (c) the risk of bias of the studies
(slope 0.0007; 95% CI−0.07 to 0.07, p= 0.984). For the sake of rigor,
we additionally report in Appendix F the eﬀect on Cannabis use of the
non-included treatment interventions that were compared with active
control conditions. In Appendix G, we report the eﬀect for studies that
employed only toxicology screening results as outcome measures.
4. Discussion
We found that digital prevention and treatment interventions are
eﬀective in reducing Cannabis use at post-treatment, with prevention
interventions producing a larger pooled eﬀect size for Cannabis use
reduction than treatment interventions. This ﬁnding is consistent with
the face-to-face Cannabis intervention literature (Bender et al., 2011;
Davis et al., 2015; Porath-Waller et al., 2010). Follow-up assessments
indicated that the post-treatment eﬀects were sustained for up to 12
months for the prevention interventions but not for the treatment in-
terventions. This indicates that digital prevention interventions are a
suitable approach to achieve a lasting small reduction in Cannabis use
in comparison with non-active control conditions.
The subgroup analyses of the prevention and treatment interven-
tions did not indicate a statistically signiﬁcant diﬀerence between
groups. However, among the treatment interventions we observed that
multi-session interventions, such as those combining CBT with MI,
produced higher eﬀect sizes (6 comparisons, g =0.18) than one-
Table 4
Subgroup analyses of associations between eﬀect sizes and study characteristics (Hedges’s g)a.
N comp g 95% CI I² 95% CI pb
Prevention studies (N=6) 6 0.33 0.13–0.54* 83 65–92
Subgroup analyses (N=6)
Intervention Parent-involvement programs 3 0.41 0.06–0.77* 90 73–76 0.36
Otherc 3 0.23 0.08–0.38** 23 0–92
Sessions in intervention Single-session 2 0.22 −0.01–0.44 52 NA 0.34
Multi-session 4 0.39 0.11–0.66** 86 64–94
Analysesd ITT analyses 3 0.38 0.03–0.43 91 76–96 0.77
Complete-case analyses 2 0.23 0.02–0.45 28 NA
Treatment studies (N=15) 17 0.12 0.02–0.22* 45 3–69
With one possible outlier removed (Towe and Stephens, 2014) 16 0.10 0.01–0.18* 31 0–62
Subgroup analyses (N=15)
Guidance Unguided 13 0.11 −0.01–0.22 44 0–71 0.81
Guided 4 0.14 −0.11–0.39 54 0–85
Intervention MI 7 0.04 −0.12–0.20 28 0–69 0.32
PNF 5 0.01 −0.11–0.30 59 0–85
MI+CBT 4 0.25 0.03–0.47* 35 0–77
Solution-focused therapy 1 0.20 0.08–0.31** 0 NA
Sessions in intervention Single-session 12 0.06 −0.06–0.18 40 0–69 0.07
Multi-session 5 0.22 0.10–0.35** 18 0–83
Recruitment Clinical 5 0.20 −0.05–0.44 50 0–82 0.88
Community 5 0.13 −0.03–0.29 21 0–67
University 5 0.09 −0.12–0.30 60 0–85
Website 2 0 −0.48–0.48 75 NA
Analysesd ITT analyses 13 0.11 0.01–0.21* 39 0–68 0.59
Complete-case analyses 3 0.23 −0.25–0.70 75 19–93
BI, brief intervention; CBT, cognitive-behavioral therapy; CI, conﬁdence interval (* p≤ 0.05; **p≤ 0.01; ***p≤ 0.001); ITT, intention-to-treat; MI, motivational
interviewing; NA, not available; N comp, number of comparisons; PNF, personalized normative feedback
a According to a random-eﬀects model.
b The p-values in this column indicate whether the diﬀerence between the eﬀect sizes in the particular subgroup is signiﬁcant.
c ‘Other’ types of interventions are PNF, a skills-based prevention program, and BI.
d In this analysis we omitted one study because the authors did not mention whether they conducted ITT or complete-case analyses.
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session interventions using approaches such as PNF, MI, and BI (13
comparisons, g=0.09); this has also been observed for digital inter-
ventions to reduce alcohol consumption (Riper et al., 2018). Our results
should be interpreted with caution, however, as subgroup analyses in
conventional meta-analyses have limited power for moderator analyses
(Kraemer et al., 2002); individual patient data meta-analyses have the
potential to overcome this obstacle (Karyotaki et al., 2017).
The outcomes of our meta-analyses are subject to certain limita-
tions. Many studies, when assessed with the Cochrane risk-of-bias tool,
satisﬁed only a small number of criteria. Our ﬁndings hence derive
largely from low-quality RCTs. Given the nature of digitally delivered
behavioral interventions, most included studies were at high risk of
performance and detection bias. Only two RCTs were able to fully blind
participants and personnel by fully automating the randomization
procedure, thus ensuring that participants were unaware of the other
conditions and that the outcome measure was unaﬀected by possible
knowledge of the received intervention (Becker et al., 2014; Jonas
et al., 2012).
As a result of limited public availability of RCT protocols or pre-
registrations, it was not possible for us to evaluate possible protocol
violations, which have been shown to aﬀect the validity of results
(Sweetman and Doig, 2011). However, we observed that recently
conducted RCTs tend to be of higher quality according to the Cochrane
risk-of-bias tool and to be more often pre-registered with published
protocols than earlier RCTs, leading to more transparency in a-priori
deﬁned research questions and in applied methods. A ﬁnal limitation is
that the applied intervention outcomes varied as to the time frames
measured (with self-reported frequencies ranging from Cannabis use in
the past week to the past six months) and the self-report questionnaires
employed. The variation in outcome measures reﬂects the lack of an
established gold standard for reporting Cannabis use frequency or
quantity, such as the standard drink units used in the alcohol use lit-
erature (Greenﬁeld and Kerr, 2008). The fact that Cannabis potency in
terms of THC diﬀers widely makes it diﬃcult to reliably measure use
without sophisticated toxicology screenings. However, toxicology
screenings have their own disadvantages, such as the inability to detect
mild Cannabis use or to reliably determine frequency of use by in-
dividuals, as well as the intrusions on the privacy of users who might
prefer to avoid face-to-face contact with professionals.
Such obstacles highlight the importance of establishing a core out-
come set for reporting Cannabis use outcomes. A recent example of such
an ongoing project from the alcohol literature is the ORBITAL project
(Shorter et al., 2017), which aims to develop an essential outcome
measure set and guidelines for the reporting of eﬃcacy and eﬀective-
ness trials involving brief interventions. A similar approach in the
Cannabis use literature is needed to improve consistency across RCTs,
minimize avoidable research waste, and improve inclusion rates in fu-
ture systematic reviews that communicate noteworthy outcomes to
stakeholders.
Regarding the observed lack of long-term eﬀects in treatment in-
terventions, we would like to point out that this shortcoming has also
been observed in Cannabis treatment interventions delivered face to
face (Gates et al., 2016). One of the interventions included in our sys-
tematic review attempted to increase and prolong the treatment eﬀect
via two booster sessions based on MI after the end of the initial inter-
vention (Blow et al., 2017). No signiﬁcant eﬀect of the booster sessions
was detected. Similarly, previous face-to-face treatment interventions
failed to show a signiﬁcant eﬀect of booster sessions in drug users
(Bogenschutz et al., 2014; Saitz et al., 2014). However, those ﬁndings
contrast with conclusions that can be drawn from the alcohol literature,
where booster sessions have previously been shown to increase or
maintain treatment eﬀects (Barnett et al., 2004; Braitman and Henson,
2016; Gwaltney et al., 2011; Wurdak et al., 2016). Similarly, a meta-
analysis on mood and anxiety disorders has previously indicated that
CBT-based booster sessions eﬀectively augment treatment eﬀect
(Gearing et al., 2013). We therefore believe it would be worthwhile to
further investigate the eﬀects of booster sessions in varied target
groups.
If we compare eﬀect sizes resulting from digital Cannabis use in-
terventions, as reported in the literature, with those of face-to-face in-
terventions, we can observe that digital prevention and treatment in-
terventions still produce smaller eﬀect sizes than face-to-face
prevention (d=0.58) and treatment interventions (g=0.49) (Davis
et al., 2015; Porath-Waller et al., 2010). In contrast, a recent meta-
analysis from the depression literature has indicated that digital inter-
vention may be equally eﬀective to face-to-face interventions
Fig. 3. Forest plot for cannabis use reduction in treatment interventions at post-treatment and follow-up (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article).
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(Carlbring et al., 2018). We are conﬁdent about the feasibility of further
enhancing the eﬀectiveness of digital interventions for Cannabis use
reduction. We therefore suggest that future studies should investigate
novel approaches for increasing the eﬀect sizes of digital interventions.
One possible approach might be to develop and assess blended inter-
ventions that combine digital and face-to-face elements of therapy. A
recent meta-analysis concluded that blended interventions might de-
crease attrition among patients, increase abstinence rates of substance
users, assist in maintaining treatment eﬀects in the long term, and re-
duce clinician time. That could translate into a cost-eﬀective alternative
to traditional treatments (Erbe et al., 2017).
5. Conclusions
Digital prevention and treatment interventions produce small, sig-
niﬁcant Cannabis use reduction eﬀects at post-treatment as compared
to non-active controls. Prevention interventions produce higher eﬀect
sizes that are later maintained at follow-up, while the follow-up eﬀects
of treatment interventions seem to be clinically negligible. Given that
prevention interventions target a range of participants that include non-
users, it would be worthwhile to explore additional outcome measures,
such as delay of Cannabis use onset, in addition to reduction of use,
since delaying the onset of Cannabis use in adolescents could sig-
niﬁcantly improve health outcomes that will last throughout adulthood
(Lisdahl et al., 2013).
Given the large number of Cannabis users and the physical and
mental health consequences associated with problematic Cannabis use,
we suggest that digital interventions have the potential to decrease
Cannabis use in a variety of target users and diﬀerent settings. They
may have a small eﬀect, but when implemented on a large scale at low
cost they could produce substantial health gains. More research is
needed, however, in the form of large, well-designed RCTs, in order to
arrive at ﬁrmer conclusions about the eﬀects of digital interventions on
Cannabis use and to enable the investigation of moderators that pos-
sibly aﬀect Cannabis use.
Future studies should, whenever possible, attempt to blind partici-
pants and personnel by fully automating the randomization procedure,
in order to ensure that participants are unaware of other conditions and
prevent performance bias. This practice would also prevent detection
bias by ensuring that outcome measures are unaﬀected by possible
knowledge of the received intervention. Furthermore, future studies
should investigate the eﬀects of booster sessions in varying target
groups, as these might be capable of increasing or maintaining treat-
ment eﬀects. Blended interventions combining digital and face-to-face
elements should also be assessed for Cannabis use reduction; these
types of interventions have previously shown promising results.
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